Cohort study of XELOX in combination with bevacizumab for unresectable or recurrent colorectal cancer.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 24 Feb 2016 Status changed from active, no longer recruiting to completed.
- 07 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 19 Jan 2011 New trial record